1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 15th April 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study 2023 Kahlert et al

Discussion in 'Long Covid research' started by Andy, Mar 12, 2023.

  1. Andy

    Andy Committee Member

    Messages:
    21,963
    Location:
    Hampshire, UK
    Abstract

    Background
    Disentangling the effects of SARS-CoV-2 variants and vaccination on the occurrence of post-acute sequelae of SARS-CoV-2 (PASC) is crucial to estimate and reduce the burden of PASC.

    Methods
    We performed a cross-sectional analysis (May/June 2022) within a prospective multicenter healthcare worker (HCW) cohort in North-Eastern Switzerland. HCW were stratified by viral variant and vaccination status at time of their first positive SARS-CoV-2 nasopharyngeal swab. HCW without positive swab and with negative serology served as controls. The sum of eighteen self-reported PASC symptoms was modeled with univariable and multivariable negative-binomial regression to analyse the association of mean symptom number with viral variant and vaccination status.

    Results
    Among 2’912 participants (median age 44 years, 81.3% female), PASC symptoms were significantly more frequent after wild-type infection (estimated mean symptom number 1.12, p<0.001; median time since infection 18.3 months), after Alpha/Delta infection (0.67 symptoms, p<0.001; 6.5 months), and after Omicron BA.1 infections (0.52 symptoms, p=0.005; 3.1 months) compared to uninfected controls (0.39 symptoms). After Omicron BA.1 infection, the estimated mean symptom number was 0.36 for unvaccinated individuals, compared to 0.71 with 1-2 vaccinations (p=0.028) and 0.49 with ≥3 prior vaccinations (p=0.30). Adjusting for confounders, only wild-type (adjusted rate ratio [aRR] 2.81, 95% confidence interval [CI] 2.08-3.83) and Alpha/Delta infection (aRR 1.93, 95% CI 1.10-3.46) were significantly associated with the outcome.

    Conclusions
    Previous infection with pre-Omicron variants was the strongest risk factor for PASC symptoms among our HCW. Vaccination prior to Omicron BA.1 infection was not associated with a clear protective effect against PASC symptoms in this population.

    Open access, https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciad143/7076063
     
    Andy, Mar 12, 2023
    #1
    Wyva, Hutan, RedFox and 2 others like this.
  2. Hutan

    Hutan Moderator Staff Member

    Messages:
    26,938
    Location:
    Aotearoa New Zealand
    I've only read the abstract, but I think this study is better than I was expecting. There is inevitably a lot of noise and confounding in studies like this, and a bigger study would have been better.

    There wasn't a finding of protection against long lasting symptoms from vaccination although, in this health worker cohort, presumably most people were vaccinated pretty early in the pandemic. Unvaccinated people would have been more likely to be infected very early in the pandemic. So, it would be hard to remove that confounding.
     
    Hutan, Mar 12, 2023
    #2
    RedFox, Sean, alktipping and 2 others like this.

Share This Page